Literature DB >> 25730328

Active surveillance for favorable risk prostate cancer.

H Ballentine Carter1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25730328     DOI: 10.1097/MOU.0000000000000167

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


× No keyword cloud information.
  1 in total

1.  Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.

Authors:  James D Brooks; Wei Wei; Jonathan R Pollack; Robert B West; Jun Ho Shin; John B Sunwoo; Sarah J Hawley; Heidi Auman; Lisa F Newcomb; Jeff Simko; Antonio Hurtado-Coll; Dean A Troyer; Peter R Carroll; Martin E Gleave; Daniel W Lin; Peter S Nelson; Ian M Thompson; Lawrence D True; Jesse K McKenney; Ziding Feng; Ladan Fazli
Journal:  Prostate       Date:  2016-06-21       Impact factor: 4.104

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.